Xenon Pharmaceuticals (XENE) Reports Q1 Loss of $0.42, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: XENE) | Delayed: 35.46 -1.04 (2.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.50 | 52 Week High | $9.75 | |||
| Open | $36.62 | 52 Week Low | $5.65 | |||
| Day High | $36.62 | P/E | N/A | |||
| Day Low | $35.28 | EPS | $0.00 | |||
| Volume | 268,149 | |||||
